Physicians Question Federal Panel's Recommendation on Prostate Screening Tests

Many healthcare professionals are questioning the U.S. Preventive Services Task Force's recent draft guidance, in which it recommends against prostate-specific antigen-based screening for prostate cancer in healthy men, according to a Florida Times-Union report.

Although David Thiel, MD, from the Mayo Clinic, agrees prostate cancer is overtreated and overdiagnosed among older men, he also believes the prostate cancer screening test is a proven life-saver.

 

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!



Another healthcare professional, Scott Eggener, MD, from the University of Chicago Medical Center, said the task force's draft guidance may be "overaggressive" and "irresponsible," according to the report. The draft guidance is subject to public comment before the task force published final recommendations on PSA screening.

Related Articles on Preventive Healthcare:

40% of Medicare Cancer Screenings Are "Medically Unnecessary"
30 Safe Practices for Better Healthcare
Coverage of Preventive Services Under New Healthcare Law Causing Confusion

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 


Patient Safety Tools & Resources Database

Featured Webinars

Featured Whitepapers